We are pleased to present the official program of the CSEA3 Annual Meeting.
The schedule below outlines keynote lectures, thematic sessions, panel discussions, and networking opportunities designed to foster the exchange of ideas and collaboration among participants.
9:00 –10:00 Registration and Coffee
10:00 – 13:00 Debate arena
| Time | Title | Speaker |
|---|---|---|
| 10:00 – 11:30 | Drug allergy | Werner Pichler (Switzerland) |
| 10:00 – 11:30 | Severe asthma | Aleksandra Kucharczyk (Poland) |
| 11:30 – 13:00 | Allergen immunotherapy (AIT) | Krzysztof Kowal (Poland) |
| 11:30 – 13:00 | In vitro diagnostics | Carmen Panaitescu (Romania) |
| 11:30 – 13:00 | Food allergy | tbd |
13:00 – 14:00 Registration and working lunch
14:00 – 14:15 Opening remarks
| CSEA3 President Dejan Dokic (North Macedonia) |
| Congress Chair Marek Jutel (Poland) |
| Congress Chair Ioana Agache (Romania) |
| Congress Chair Radoslaw Gawlik (Poland) |
14:15 – 16:45 SESSION: Novel avenues for immune modulation
CHAIRS:
- Radoslaw Gawlik (Poland)
- Ioana Agache (Romania)
| Time | Title | Speaker |
|---|---|---|
| 14:15 – 14:45 | New insights from asthma | Luis Pérez de Llano (Spain) |
| 14:45 – 15:15 | New insights from CRS | Whitney Stevens (US) |
| 15:15 – 15:45 | New insights from AD | Ester Del Duca (Italy) |
| 15:45 – 16:15 | Strategies for prevention and management of severe reactions in food allergy | Anna Nowak-Wegrzyn (US) |
| 16:15 – 16:45 | AIT versus biologicals | Marek Jutel (Poland) |
16:45 – 17:15 Coffee Break & Poster Session
17:15 – 18:45 SESSION: Type V, VI and VII asthma
CHAIRS:
- Luis Pérez de Llano (Spain)
- Werner Pichler (Switzerland)
| Time | Title | Speaker |
|---|---|---|
| 17:15 – 17:45 | Mechanisms and biomarkers | Ioana Agache (Romania) |
| 17:45 – 18:15 | The impact of biologicals | Celeste Porsbjerg (Denmark) |
| 18:15 – 18:45 | Achieving long-term treatment benefits in severe asthma patients | Peter Howarth (UK) |
18:45 – 19:30 Industry Session - ALK | AIT in the multimorbid patient: opportunities and pitfalls
CHAIRS:
- Ioana Agache (Romania)
| Time | Title | Speaker |
|---|---|---|
| 18:45 – 18:55 | Introduction: Rationale for AIT in multimorbid allergic patients. | Ioana Agache (Romania) |
| 18:55 – 19:05 | AIT and severe asthma | Marek Jutel (Poland) |
| 19:05 – 19:15 | AIT and atopic dermatitis | Radosław Gawlik (Poland) |
| 19:15 – 19:25 | AIT and autoimmunity | Krzysztof Kowal (Poland) |
19:30 – 21:00 Standing dinner
08:30 – 10:00 SESSION: Biomarkers
CHAIRS:
- Magdalena Zemelka-Wiącek (Poland)
- Carmen Panaitescu (Romania)
| Time | Title | Speaker |
|---|---|---|
| 08:30 – 08:50 | Immunophenotyping of peripheral blood eosinophils in patients with asthma | Jakub Novosad (Czech Republic) |
| 08:50 – 09:10 | Genetic markers of nasal polyposis and asthma: insights from Croatian patients | Anamarija Štajduhar (Croatia) |
| 09:10 – 09:30 | The small airways syndrome | Maciej Kupczyk (Poland) |
| 09:30 – 10:00 | The potential of skin tapes | Ester del Duca (Italy) |
10:00 – 10:30 Coffee Break & Poster Session
10:30 – 11:30 Industry Session - GSK | The future of biological treatment for severe asthma patients
CHAIRS:
- Piotr Kuna (Poland)
| Time | Title | Speaker |
|---|---|---|
| 10:30 – 10:35 | Evolution of biological treatment of asthma | Piotr Kuna (Poland) |
| 10:35 – 10:55 | Depemokimab: Ultra Long-Acting biological for severe asthma | Maciej Kupczyk (Poland) |
| 10:55 – 11:15 | Ultra-long-acting drugs in the treatment of respiratory diseases – what do they bring to clinical practice? | Radosław Gawlik (Poland) |
| 11:15 – 11:30 | Persistence of the biological treatment effect in severe asthma – review of the published data | Alicja Majos (Poland) |
10:30 – 11:30 Industry session - Stallergenes Greer | Workshop in Polish
| Time | Title | Speaker |
|---|---|---|
| 10:30 – 11:30 | Warsztaty (prowadzone w języku polskim): Immunoterapia w praktyce klinicznej – aktualna wiedza i interesujące przypadki kliniczne | Paweł Majak (Poland) |
11:30 – 13:00 SESSION: Pediatric allergy
CHAIRS:
- Anna Nowak-Wegrzyn (US)
- Mira Pevec (Croatia)
| Time | Title | Speaker |
|---|---|---|
| 11:30 – 12:00 | The efficacy and safety of immunotherapy in children with food allergy | Sharon Chinthrajah (US) |
| 12:00 – 12:30 | Point-of-care blood eosinophils to predict preschool wheeze attacks | Sejal Saglani (UK) |
| 12:30 – 12:45 | Clinical manifestations of atopy in children | Dejan Djokić (North Macedonia) |
| 12:45 – 13:00 | Early presentation of hereditary angioedema symptoms in a 2-year-old boy | Jūratė Staikūnienė-Kozonis (Lithuania) |
13:00 – 14:00 Working Lunch
14:00 – 15:30 SESSION Allergy and the environment
CHAIRS:
- Tonya Winders (US)
- Maris Bukovskis (Latvia)
| Time | Title | Speaker |
|---|---|---|
| 14:00 – 14:30 | Climate change and aeroallergens | Athanasios Damialis (Greece) |
| 14:30 – 15:00 | Nature-based solutions | Tari Haahtela (Finland) |
| 15:00 – 15:30 | Environmental endotypes | Ioana Agache (Romania) |
14:15 – 15:15 Industry session - ALK | Workshop in Polish
| Time | Title | Speaker |
|---|---|---|
| 14:15 – 15:15 | Warsztaty (prowadzone w języku polskim): Wstrząs anafilaktyczny w praktyce: rozpoznanie i podawanie adrenaliny |
Karina Jahnz-Różyk Radosław Gawlik Anna Kosowska Marek Jutel (Poland) |
15:30 – 16:00 Coffee Break & Poster Session
16:00 – 17:30 SESSION: The old and new of AIT
CHAIRS:
- Vera Mahler (Germany)
- Laura Malinauskienė (Lithuania)
| Time | Title | Speaker |
|---|---|---|
| 16:00 – 16:20 | Experiences with an ultra-rush protocol for the initiation of hymenoptera venom immunotherapy using depot preparations | Tomáš Balner (Czech Republic) |
| 16:20 – 16:40 | Venom allergy – diagnosis and treatment | Peter Kopač (Slovenia) |
| 16:40 – 17:00 | Status of AIT in Central and Eastern Europe – results of the CSEA3 survey | Magdalena Zemelka-Wiacek (Poland) |
| 17:00 – 17:30 | New AIT Guidelines | Marek Jutel (Poland) |
17:30 – 18:30 SESSION: Industry session - Stallergenes Greer | in Polish
| Time | Title | Speaker |
|---|---|---|
| 17:30 – 18:30 | (prowadzone w języku polskim): Immunoterapia alergenowa (AIT) w niejednoznacznych przypadkach klinicznych – aspekty diagnostyczno-terapeutyczne |
Marek Jutel (Poland) Marita Nittner-Marszalska (Poland) |
08:30 – 10:30 SESSION: In vivo vs in vitro allergy diagnosis
CHAIRS:
- Karina Jahnz-Różyk (Poland)
- tbd
| Time | Title | Speaker |
|---|---|---|
| 08:30 – 08:50 | Assessment of rhinitis using the exposure chamber | Magdalena Zemelka-Wiacek (Poland) |
| 08:50 – 09:20 | Molecular allergology in daily practice | Joana Vitte (France) |
| 09:20 – 09:50 | Ensuring the quality of diagnostic tests | Vera Mahler (Germany) |
| 09:50 – 10:15 | Novel techniques for skin testing | Sven Seys (Belgium) |
| 10:15 – 10:30 | Diagnosing contact allergy | Laura Malinauskiene (Lithuania) |
10:30 – 11:00 Coffee Break & Poster Session
11:00 – 12:45 SESSION: Management at the point of care
CHAIRS:
- Tomáš Balner (Czech Republic)
- tbd
| Time | Title | Speaker |
|---|---|---|
| 11:00 – 11:30 | Co-creation of the management plan | Tonya Winders (US) |
| 11:30 – 11:55 | Biological treatment of chronic rhinosinusitis with polyps -real-life experience | Radoslaw Gawlik (Poland) |
| 11:55 – 12:20 | Asthma management | Marcin Moniuszko (Poland) |
| 12:20 – 12:45 | Drug and food allergy | Iwona Poziomkowska-Gęsicka (Poland) |
